Why aspirin is the correct first action
A
58-year-old man with crushing substernal chest pain at rest, hypertension, and a smoking history presents a classic picture of acute coronary syndrome (ACS). The standing orders include several anti-ischemic agents, but only one can be given immediately without violating a safety contraindication:
aspirin.
Aspirin 325 mg chewed and swallowed is the priority because it rapidly inhibits platelet cyclooxygenase, reducing thromboxane A2 production and limiting further platelet aggregation at the site of a ruptured coronary plaque. The patient has no allergy and no bleeding history, so there is no contraindication. Chewing non-enteric-coated aspirin allows buccal and gastric absorption, producing a measurable antiplatelet effect within
15–20 minutes — far faster than swallowing an enteric-coated tablet whole.
Key point! In suspected ACS, aspirin is given to every patient unless there is a true aspirin allergy, active bleeding, or a recent major bleeding event. It is the one order here that fits every stated premise without qualification.
Why nitroglycerin must be held
The patient took
sildenafil at
20:00 the previous evening. The current time is
10:00, meaning only
14 hours have elapsed. Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that potentiates the vasodilatory effect of nitric oxide. Nitroglycerin also works through the nitric oxide pathway, so combining the two can cause profound, refractory hypotension.
Nitrates are contraindicated within 24 hours of sildenafil use because the additive vasodilation can drop blood pressure to life-threatening levels. The patient’s current blood pressure of
136/84 mmHg is stable, but giving nitroglycerin now could precipitate a dangerous fall. The 24-hour window is a hard stop, not a suggestion.
Watch out! Always ask about PDE5 inhibitor use before giving any nitrate — including sublingual, transdermal, or intravenous forms. The question of “when did you last take it” is as important as the chest pain history itself.
Why oxygen is not indicated now
The patient’s
SpO2 is
96% on room air. Routine oxygen administration in ACS has not been shown to reduce infarct size or mortality in patients who are not hypoxemic. Current practice reserves supplemental oxygen for patients with
SpO2 below 90%, respiratory distress, or other signs of inadequate oxygenation.
Oxygen is not a treatment for ischemic pain itself; it is a treatment for hypoxemia. Giving
4 L/min by nasal cannula to a patient with normal saturation adds no benefit and may theoretically cause coronary vasoconstriction through hyperoxia. The standing order for oxygen should be held unless the patient’s saturation drops.
Why morphine is deferred
Morphine reduces preload, afterload, and sympathetic tone, which lowers myocardial oxygen demand. However, it is not a first-line anti-ischemic agent.
Opioids are reserved for pain that persists despite adequate anti-ischemic therapy, including aspirin, nitrates when safe, and beta-blockade when indicated. Giving morphine first would mask ongoing ischemia without addressing the underlying thrombotic process. It also carries risks of respiratory depression, hypotension, and nausea.
The correct sequence in ACS is to start antiplatelet therapy immediately, then add anti-ischemic agents as tolerated. Morphine is a later adjunct, not an opening move.
Putting the orders in priority order
| Order | Can it be given now? | Reason |
|---|
| Aspirin 325 mg chewed | Yes — give immediately | No contraindication; rapid antiplatelet effect reduces mortality in ACS |
| Nitroglycerin 0.4 mg SL | No — hold | Sildenafil within 24 hours; risk of severe hypotension |
| Oxygen 4 L/min NC | No — hold | SpO2 is 96%; oxygen only for SpO2 below 90% or respiratory distress |
| Morphine 2 mg IV | No — defer | Reserved for refractory pain after anti-ischemic therapy |
The nurse should carry out the aspirin order now, document the sildenafil use prominently, and notify the provider that nitroglycerin is contraindicated for the next
10 hours. The other orders remain available for reassessment as the clinical picture evolves.